Tetrameric RGD induces clustering of integrin αvβ3 on the melanoma cell surface and decreases cell viability
- Авторлар: Rubtsov M.A.1,2,3, Maslakova A.A.1,2, Potashnikova D.M.1, Veiko V.P.4, Syrkina M.S.1,2,4
- 
							Мекемелер: 
							- Department of Biology
- LIA 1066 French–Russian Joint Cancer Research Laboratory, Department of Biology
- Sechenov First Moscow State Medical University
- Bach Institute of Biochemistry, Biotechnology Research Center
 
- Шығарылым: Том 71, № 4 (2016)
- Беттер: 227-235
- Бөлім: Article
- URL: https://journals.rcsi.science/0027-1314/article/view/163273
- DOI: https://doi.org/10.3103/S0027131416040076
- ID: 163273
Дәйексөз келтіру
Аннотация
The recombinant hybrid protein SR15 composed of streptavidin fused with RGD peptide is obtained. The ability of this protein to recognize human melanoma cells (MeWo line) is demonstrated. Types of expressed RGD-binding integrins in the cells of this line are identified. It is found that the recombinant hybrid protein SR15 binds to integrin αvβ3 on the surface of human melanoma cells. The binding to the protein SR15 results in clustering of αvβ3 receptors on the surface of MeWo cells, internalization of the recombinant protein, and an almost twofold decrease in cell viability.
Негізгі сөздер
Авторлар туралы
M. Rubtsov
Department of Biology; LIA 1066 French–Russian Joint Cancer Research Laboratory, Department of Biology; Sechenov First Moscow State Medical University
														Email: krimsy@yandex.ru
				                					                																			                												                	Ресей, 							Moscow; Moscow; Moscow						
A. Maslakova
Department of Biology; LIA 1066 French–Russian Joint Cancer Research Laboratory, Department of Biology
														Email: krimsy@yandex.ru
				                					                																			                												                	Ресей, 							Moscow; Moscow						
D. Potashnikova
Department of Biology
														Email: krimsy@yandex.ru
				                					                																			                												                	Ресей, 							Moscow						
V. Veiko
Bach Institute of Biochemistry, Biotechnology Research Center
														Email: krimsy@yandex.ru
				                					                																			                												                	Ресей, 							Moscow						
M. Syrkina
Department of Biology; LIA 1066 French–Russian Joint Cancer Research Laboratory, Department of Biology; Bach Institute of Biochemistry, Biotechnology Research Center
							Хат алмасуға жауапты Автор.
							Email: krimsy@yandex.ru
				                					                																			                												                	Ресей, 							Moscow; Moscow; Moscow						
Қосымша файлдар
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  
  
  Мақаланы E-mail арқылы жіберу
			Мақаланы E-mail арқылы жіберу  Ашық рұқсат
		                                Ашық рұқсат Рұқсат берілді
						Рұқсат берілді Тек жазылушылар үшін
		                                		                                        Тек жазылушылар үшін
		                                					